Please login to the form below
Bristol Myers Squibb announces data on Zeposia from DAYBREAK study in MS
The data presented at ECTRIMS 2021 reinforces the efficacy and safety profile of Zeposia (ozanimod) in patients with relapsing forms of multiple sclerosis
Merck and Ridgeback request EUA from US FDA for COVID-19 drug molnupiravir
If authorised, molnupiravir could be the first oral antiviral medicine for the treatment of mild-to-moderate COVID-19 in at risk adults
bluebird bio provides update on 2seventy bio spin-off
The company has also announced the appointment of two new board members, Najoh Tita-Reid and Sarah Glickman
World Mental Health Day is on 10 October
You Okay, Doc? A call for more awareness and support for the mental health of doctors
Merck to acquire Acceleron in a deal worth around $11.5bn
The acquisition of the biopharmaceutical company will complement and strengthen Merck’s cardiovascular pipeline
Rocky start for Biogen’s Alzheimer’s drug Aduhelm
Controversial Alzheimer’s treatment Aduhelm is struggling to realise its potential, with only 100 patients receiving the therapy so far in the US
Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%
New data showing Gilead’s Veklury cuts the risk of hospitalisation for COVID-19 contradicts results of the World Health Organization’s Solidarity study
AstraZeneca chooses Ireland for $360m manufacturing site
The next-generation facility will make small molecule active ingredients, future-proofing the company’s supply chain and boosting the Irish life sciences sector
New data for Tecentriq in early-stage lung cancer
Roche’s PD-L1 blocker reduced the risk of disease recurrence and death for patients with stage 2-3a non-small cell lung cancer following surgery
Italy accelerates the path towards digital therapeutics implementation
PME talks to Roberto Ascione, Gualberto Gussoni and Giuseppe Recchia about the advancement of digital therapeutics in Italy
-
Who's calling the shots in European healthcare?Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis
-
The shifting healthcare landscape
-
Strong five-year survival data for Kisqali in breast cancerNovartis’ Kisqali plus letrozole offers more than a year survival benefit for postmenopausal women with HR+/HER2 advanced breast cancer
-
Biogen’s Vumerity recommended by CHMP in MSA thumbs up for Vumerity in the EU could ease the way for Biogen’s follow-up to Tecfidera in multiple sclerosis
-
UK announces COVID boosters for a “bumpy winter” aheadA single shot of Pfizer’s COVID-19 vaccine will be offered to 30 million people in the UK including those 50 or over and frontline health and social care workers
-
AbbVie signs gene therapy deal in eye careAbbVie and REGENXBIO have teamed up on RGX-314, a potential one-time gene therapy against two leading causes of blindness, wet AMD and diabetic retinopathy.
-
Embattled Biogen talks up Aduhelm
Biogen CEO admitted the company was experiencing “near-term challenges” after the controversial approval of Alzheimer’s drug, Aduhelm
-
Results for the inaugural QiC Dermatology Awards 2021 in association with Dermatology in practice announced!The awards took place at the Reading office of the QiC Dermatology Awards sponsor, Sanofi Genzyme
-
Dovetail wins Communiqué Agility and Flexibility award at Communiqué 2021This inaugural award was given to Dovetail amid fierce competition from four other agencies
-
David Hunt launches independent agency The ConsideredThe team includes Professor Shafi Ahmed, Aurora Archer, Jane Kidd and CCO Pete Armstrong
-
Amanda Pritchard becomes NHS England’s first female chief executivePritchard takes on the chief executive role after serving as the NHS’ chief operating officer for two years
-
NICE looks internally for new chief executive Deputy chief exec Gillian Leng is set to take the helm
-
Paris biocluster appoints Stéphane Roques as new chiefFormer general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment
-
Picker appoints new CEOChris Graham to focus on person-centred care
Latest healthcare appointments
COVID-19 Updates and Daily News
Featured jobs
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
Senior Account Manager
-
Competitive salary offered
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
- US demand for COVID-19 antibody treatments rising fast
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Assessing the value of interim analyses in clinical trials
- Live Webinar: Accelerating Revenue Cycle Performance in the Healthcare Industry
- The FDA vaccine advisory board recommends booster shots of both the J&J and Moderna vaccines
- Biogen's ALS drug tofersen misses phase 3 endpoint
- AZ’s Imfinzi combination shows promise in liver cancer
- Gilead’s Trodelvy set for EU approval in breast cancer
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Novo Nordisk settles US insulin pricing dispute for $100m
- The FDA vaccine advisory board recommends booster shots of both the J&J and Moderna vaccines
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- bluebird bio provides update on 2seventy bio spin-off
- Award-winning health agency 90TEN launches in the US
PMHub
TRIDUCIVE
Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...
Latest intelligence
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
- News:
- Senior Analytics Specialist joins Research Partnership...
